ALK and anaplastic large cell lymphoma: In addition to ALK inhibitor agents, vinblastine is another promising novel agent that is being investigated in various ongoing strategies for ALCL, since the first report demonstrating the high efficacy of vinblastine in patients with relapsed ALCL (24).